AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
R&D Costs, Rx Prices, and the Formula for Success in Life Sciences Innovation, With Stephen Ezell
Innovation Files: Where Tech Meets Public Policy
Is There a Conflict Between Intellectual Property Rights and Access to Medicines?
The biopharm industry is on corse to produce 12 billion vaccines globally this year. The problem becomes distribution of these vaccines intoa accumunities across the world. Many have used this situation to launch a broad frontal assault intellectual property rights in the liest sciences industry. What's more important: access to current medicines at a low price, or future medicines for our kids? And i think there's a way to square that circle if we focus on enabling a robust business eco system including the ability to make money on successful drugs.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode